| Literature DB >> 35992820 |
Armin Fereidouni1,2, Mahmood Salesi3, Maryam Rassouli4, Fariba Hosseinzadegan5, Mohammad Javid6, Maryam Karami7, Maryam Elahikhah6, Salman Barasteh8,9.
Abstract
Background: More than 50,000 deaths in terms of cancer occur annually in Iranian hospitals. Determining the preferred place of end-of-life care and death for cancer patients in Iran is a quality marker for good end-of-life care and good death. The purpose of this study was to determine the preferred place of end-of-life care and death in cancer patients. Method: In 2021, the current descriptive cross-sectional investigation was carried out. Using the convenience sample approach, patients were chosen from three Tehran referral hospitals (the capital of Iran). A researcher-made questionnaire with three parts for demographic data, clinical features, and two questions on the choice of the desired location for end-of-life care and the death of cancer patients served as the data collecting instrument. Data were analyzed using SPSS software version 18. The relationship between the two variables preferred place for end-of-life care and death and other variables was investigated using chi-square, Fisher exact test, and multiple logistic regression. Result: The mean age of patients participating in the study was 50.21 ± 13.91. Three hundred ninety (69.6%) of the patients chose home, and 170 (30.4%) patients chose the hospital as the preferred place of end-of-life care. Choosing the home as a preferred place for end-of-life care had a significant relationship with type of care (OR = .613 [95% CI: 0.383-0.982], P = .042), level of education (OR = 2.61 [95% CI: 1.29-5.24], P = 0.007), type of cancer (OR = 1.70 [1.01-2.89], P = .049), and income level (Mediate: (OR: 3.27 (1.49, 7.14), P = .003) and Low: (OR: 3.38 (1.52-7.52), P = .003). Also, 415 (75.2%) patients chose home and 137 (24.8%) patients chose hospital as their preferred place of death. Choosing the home as a preferred place of death had a significant relationship with marriage (OR = 1.62 [95% CI: 1.02-2.57], P = .039) and time to diagnostic disease less than 6 months (OR = 1.62 [95% CI: 0.265-0.765], P = .002).Entities:
Keywords: Iran; cancer; end of life; hospice; palliative care; preferred place of care; preferred place of death
Year: 2022 PMID: 35992820 PMCID: PMC9382894 DOI: 10.3389/fonc.2022.911397
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 5.738
Demographic and clinical characteristics of the 564 cancer patients.
| Variable | Categories | n (%) |
|---|---|---|
|
| Outpatient | 435 (77.1%) |
| Inpatient | 129 (22.9%) | |
|
| Male | 189 (33.5%) |
| Female | 375 (66.5%) | |
|
|
| 50.21 ± 13.91 |
| 18–40 | 154 (27.3%) | |
| 40–60 | 276 (48.9%) | |
| >60 | 134 (23.8%) | |
|
| Single | 126(22.4%) |
| Married | 437(77.6%) | |
|
|
| 2.55 ± 1.88 |
| 0 | 67 (12.2%) | |
| 1-3 | 366 (66.7%) | |
| ≥4 | 116 (21.1%) | |
|
| Elementary | 186 (33.8%) |
| High school | 267 (48.5%) | |
| Academic | 98 (17.8%) | |
|
| Employed | 126 (22.6%) |
| Unemployed | 431 (77.4%) | |
|
| Fars | 264 (47.1%) |
| Lor | 52 (9.3%) | |
| Tork | 151 (26.9%) | |
| Kord | 78 (13.9%) | |
| Other | 16 (2.9%) | |
|
| High | 42 (7.6%) |
| Mediate | 306 (55.4%) | |
| Low | 204 (37%) | |
|
| Gastrointestinal | 144 (28.5%) |
| Breast | 219 (43.4%) | |
| Blood | 59 (11.7%) | |
| Other | 83 (16.4%) | |
|
| Tamin ejtemaee | 214 (38.2%) |
| Military | 203 (36.3%) | |
| Other | 143 (25.5%) | |
|
|
| 24.83 ± 26.18 |
| ≤6 | 162 (30%) | |
| >6 | 378 (70%) | |
|
| Hospital | 170 (30.4%) |
| Home | 390 (69.6%) | |
|
| Hospital | 137 (24.8%) |
| Home | 415 (75.2%) |
*SD, standard deviation.
Figure 1Preferred place of care and death of patients with cancer disease.
Correlations between variables and the preferred place of end-of-life care in cancer patients.
| Multiple logistic model | ||||||
|---|---|---|---|---|---|---|
| Variable | Categories | HospitalN (%) | HomeN (%) | P-value | *OR (**CI 95%) | P-value |
|
| Outpatient | 118 (27.4%) | 313 (72.6%) | 0.005 | Base Category | |
| Inpatient | 52 (40.3%) | 77 (59.7%) | .613 (.383,.982) | .042 | ||
|
| Male | 71 (37.8%) | 117 (62.2%) | 0.007 | ||
| Female | 99 (26.6%) | 273 (73.4%) | ||||
|
| 18-40 | 43 (28.1%) | 110 (71.9%) | 0.084 | ||
| 40-60 | 76 (27.8%) | 197 (72.2%) | ||||
| >60 | 51 (38.1%) | 83 (61.9%) | ||||
|
| single | 39 (31.2%) | 86 (68.8%) | 0.78 | ||
| married | 130 (30.0%) | 304 (70%) | ||||
|
| 0 | 18 (26.9%) | 49 (73.1%) | 0.19 | ||
| 1-3 | 102 (28.1%) | 261 (71.9%) | ||||
| ≥4 | 42 (36.5%) | 73 (63.5%) | ||||
|
| Elementary | 74 (40.4%) | 109 (59.6%) | 0.000 | Base Category | |
| High school | 68 (25.6%) | 198 (74.4%) | 1.51 (.907, 2.51) | .113 | ||
| academic | 22 (22.4%) | 76 (77.6%) | 2.61 (1.29, 5.24) | .007 | ||
|
| Employed | 40 (31.7%) | 86 (68.3%) | 0.74 | ||
| Unemployed | 129 (30.2%) | 298 (69.8%) | ||||
|
| Fars | 63 (24%) | 199 (76%) | 0.013 | ||
| Lor | 15 (28.8%) | 37 (71.2%) | ||||
| Tork | 52 (34.9%) | 97 (65.1%) | ||||
| Kord | 31 (39.7%) | 47 (60.3%) | ||||
| other | 8 (50%) | 8 (50%) | ||||
|
| High | 24 (57.1%) | 18 (42.9%) | 0.003 | Base Category | |
| Mediate | 90 (29.6%) | 214 (70.4%) | 3.27 (1.49, 7.14) | .003 | ||
| low | 54 (26.7%) | 148 (73.3%) | 3.38 (1.52, 7.52) | .003 | ||
|
| Gastrointestinal | 52 (36.1%) | 92 (63.9%) | 0.006 | Base Category | |
| Breast | 47 (21.6%) | 171 (78.4%) | 1.70 (1.01, 2.89) | .049 | ||
| Blood | 23 (39.7%) | 35 (60.3%) | .65 (.33, 1.29) | .225 | ||
| other | 25 (30.1%) | 58 (69.9%) | 1.32 (.71, 2.46) | .381 | ||
|
| ***Social security | 50 (23.5%) | 163 (76.5%) | 0.006 | ||
| ****military | 63 (31.3%) | 138 (68.7%) | ||||
| other | 56 (39.2%) | 87 (60.8%) | ||||
|
| ≤6 | 55 (34%) | 107 (66%) | 0.14 | ||
| >6 | 104 (27.7%) | 271 (72.3%) | ||||
*OR, odds ratio; **CI, confidence interval.
***Funder: Social Security Organization.
**Funder: Military Organization.
Correlations between variables and the preferred place of death of cancer patients.
| Multiple logistic model | ||||||
|---|---|---|---|---|---|---|
| Variable | Categories | HospitalN (%) | HomeN (%) | P value | OR (CI 95%) | P-value |
|
| Outpatient | 109 (25.7%) | 315 (74.3%) | 0.379 | ||
| Inpatient | 28 (21.9%) | 100 (78.1%) | ||||
|
| Male | 41 (22.7%) | 140 (77.3%) | 0.41 | ||
| Female | 96 (25.9%) | 275 (74.1%) | ||||
|
| 18-40 | 45 (30.2%) | 104 (69.8%) | 0.13 | ||
| 40-60 | 58 (21.4%) | 213 (78.6%) | ||||
| >60 | 34 (25.8%) | 98 (74.2%) | ||||
|
| Single | 41 (33.3%) | 82 (66.7%) | 0.014 | Base category | |
| Married | 96 (22.4%) | 332 (77.6%) | 1.62 (1.02, 2.57) | .039 | ||
|
| 0 | 16 (24.6%) | 49 (75.4%) | 0.67 | ||
| 1-3 | 93 (25.8%) | 268 (74.2%) | ||||
| ≥4 | 24 (21.6%) | 87 (78.4%) | ||||
|
| Elementary | 43 (23.8%) | 138 (76.2%) | 0.65 | ||
| High school | 65 (24.7%) | 198 (75.3%) | ||||
| academic | 25 (26.3%) | 70 (73.7%) | ||||
|
| Employed | 26 (21.1%) | 97 (78.9%) | 0.27 | ||
| Unemployed | 110 (25.9%) | 314 (74.1%) | ||||
|
| Fars | 56 (21.8%) | 201 (78.2%) | 0.43 | ||
| Lor | 11 (21.6%) | 40 (78.4%) | ||||
| Tork | 44 (29.9%) | 103 (70.1%) | ||||
| Kord | 21 (26.9%) | 57 (73.1%) | ||||
| other | 4 (25%) | 12 (75%) | ||||
|
| High | 12 (28.6) | 30 (71.4%) | 0.92 | ||
| Mediate | 73 (24.3) | 228 (75.7%) | ||||
| low | 51 (25.5) | 149 (74.5%) | ||||
|
| Gastrointestinal | 29 (20.4) | 113 (79.6%) | 0.28 | ||
| Breast | 63 (28.9) | 155 (71.1%) | ||||
| Blood | 14 (24.6) | 43 (75.4%) | ||||
| other | 18 (22) | 64 (78%) | ||||
|
| Social security | 57 (27) | 154 (73%) | 0.011 | ||
| military | 35 (17.9) | 161 (82.1%) | ||||
| other | 45 (31.5) | 98 (68.5%) | ||||
| Time to diagnostic disease ( | ≤6 | 24 (15.1) | 135 (84.9%) | 0.002 | Base category | |
| >6 | 104 (28) | 268 (72%) | .468 (.286,.765) | .002 | ||
OR, odds ratio; CI, confidence interval.